Page last updated: 2024-09-03

rp 170 and doranidazole

rp 170 has been researched along with doranidazole in 1 studies

Compound Research Comparison

Studies (rp 170)	Trials (rp 170)	Recent Studies (post-2010) (rp 170)	Studies (doranidazole)	Trials (doranidazole)	Recent Studies (post-2010) (doranidazole)
9	0	0	30	4	10

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Miyata, Y; Mori, T; Murayama, C; Nishio, A; Sakaguchi, M; Sato, C; Shoji, T; Suzuki, A; Suzuki, T; Tanabe, Y	1

Other Studies

1 other study(ies) available for rp 170 and doranidazole

Article	Year
Radiosensitization by a new potent nucleoside analog: 1-(1',3',4'-trihydroxy-2'-butoxy)methyl-2-nitroimidazole(RP-343). International journal of radiation oncology, biology, physics, 1993, Jun-15, Volume: 26, Issue:3 Topics: Animals; Cell Hypoxia; Cell Survival; Dogs; Dose-Response Relationship, Drug; Etanidazole; Female; In Vitro Techniques; Injections, Intravenous; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Neoplasms, Experimental; Nitroimidazoles; Nucleosides; Radiation-Sensitizing Agents	1993

Article

Year

Radiosensitization by a new potent nucleoside analog: 1-(1',3',4'-trihydroxy-2'-butoxy)methyl-2-nitroimidazole(RP-343).

International journal of radiation oncology, biology, physics, 1993, Jun-15, Volume: 26, Issue:3

Topics: Animals; Cell Hypoxia; Cell Survival; Dogs; Dose-Response Relationship, Drug; Etanidazole; Female; In Vitro Techniques; Injections, Intravenous; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Neoplasms, Experimental; Nitroimidazoles; Nucleosides; Radiation-Sensitizing Agents

1993